WAYNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that Aclaris’ Chief Executive Officer Neal Walker and other members of the Aclaris senior leadership team will participate in a fireside chat during the virtual HC Wainwright “HCW@Home” series. The virtual fireside chat will take place on Friday May 16, 2025, at 1:00 PM EDT. A live a ...

Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter gross margin of 6%, representing a 33-percentage point improvement compared to the first quarter of 2024.Announced a global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates in the U.S. as MilliporeSigma (“MilliporeSigma ...

Core Viewpoint - i-80 Gold Corp. has announced a bought deal offering of 270 million units at a price of US$0.50 per unit, aiming to raise gross proceeds of US$135 million to support its development plan in Nevada and for general corporate purposes [1][4]. Group 1: Offering Details - The offering consists of 270,000,000 units, each comprising one common share and one-half of a common share purchase warrant, with the warrant allowing the purchase of one common share at US$0.70 for 30 months post-closing [2]. - An over-allotment option has been granted to underwriters for an additional 15% of the base offering, potentially raising up to US$20.25 million if exercised [3]. - The expected closing date for the offering is around May 16, 2025, subject to necessary corporate and regulatory approvals [5]. Group 2: Use of Proceeds - The net proceeds from the offering, including any additional funds from the over-allotment option, will be allocated towards growth expenditures related to i-80's new development plan in Nevada and for general corporate purposes [4]. Group 3: Company Overview - i-80 Gold Corp. is focused on becoming a mid-tier gold producer in Nevada, holding significant gold mineral resources and advancing high-grade exploration projects [10]. - The company operates a fully permitted central processing facility and is implementing a hub-and-spoke mining and processing strategy to enhance efficiency and growth [10].

Castellum, Inc. Reports First Year-Over-Year Organic Revenue Growth with Q1 2025 Results Castellum, Inc. ("Castellum" or the "Company") (NYSE-American: CTM) announces revenue for the first quarter of 2025 was $11.7 million, an increase from $10.3 million in the fourth quarter of 2024 and up from $11.3 million in the first quarter of 2024 - www.castellumus.com VIENNA, Va., May 09, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. ("Castellum" or the "Company") (NYSE-American: CTM), a cybersecurity, electronic war ...

PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six month periods ended March 31, 2025. "This quarter’s financial results were once again slightly ahead of our prior expectations, as our teams executed well, which included driving an acceleration in our free-cash flow generation, thereby allowing us to continue to repay debt and create additional balance sheet flex ...

LAS VEGAS, May 09, 2025 (GLOBE NEWSWIRE) -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), today announced that its indirectly owned subsidiary BitNile.com, Inc. (“Bitnile.com”), officially launched the Nile Coin (NILE) (“Nile Coin”) on the Solana Blockchain on May 3, 2025. Bitnile.com, a U.S.-based social gaming platform, minted 500 billion Nile Coin and the current market capitalization as of May 8, 2025, is approximately $164.5 million, ba ...

Achieved Q1 guidance on both Ex-TAC gross profit and Adjusted EBITDA; CTV revenues grow by more than 100% year-over-year on pro forma basis; Integration and synergies remain on track; Reiterates full year 2025 guidanceNEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (Nasdaq: OB), which is operating under the new Teads brand following Outbrain’s acquisition of Teads in February 2025, announced today financial results for the quarter ended March 31, 2025. First Quarter 2025 Key Financial Metrics1: Th ...

- Earnings Call Scheduled for 9:00 PM ET on May 26, 2025 -SHANGHAI, China, May 09, 2025 (GLOBE NEWSWIRE) -- Hesai Group (“Hesai,” “Hesai Technology” or the “Company”) (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced that it will report its first quarter 2025 unaudited financial results on Monday, May 26, 2025, after the close of U.S. markets. The Company’s management will host an earnings conference call at 9:00 PM U.S. Eastern Time on May ...

Seoul, South Korea, May 09, 2025 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games based in South Korea, today announced its unaudited financial results for the first quarter ended March 31, 2025, prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board and business updates. FIRST QUARTER 2025 HIGHLIGHTS Total revenues were KRW 137,464 million (US$ 93,2 ...

SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, presented results from the Phase 2b SYMMETRY trial demonstrating the potential of efruxifermin (EFX) to improve fibrosis in compensated cirrhosis (F4) caused by metabolic dysfunction-associated steatohepatitis (MASH), in a late-breaking oral presentation at the Eur ...